Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

29.36
+0.74502.60%
Post-market: 29.460.1000+0.34%16:27 EDT
Volume:4.44M
Turnover:131.45M
Market Cap:3.30B
PE:-25.46
High:30.28
Open:29.19
Low:29.09
Close:28.62
Loading ...

Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?

Zacks
·
11 Mar

Viking Therapeutics Signs Manufacturing Deal With CordenPharma for Obesity Program

MT Newswires Live
·
11 Mar

Viking Therapeutics Signs Broad Manufacturing Agreement With CordenPharma to Support Commercialization of VK2735

PR Newswire
·
11 Mar

H.C. Wainwright says Novo results support Viking obesity potential

TIPRANKS
·
10 Mar

Promising Potential of Viking Therapeutics’ VK2735 in Obesity and Diabetes Treatment Drives Buy Rating

TIPRANKS
·
10 Mar

Viking Therapeutics, Inc. (VKTX) Beats Stock Market Upswing: What Investors Need to Know

Zacks
·
08 Mar

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
08 Mar

Analysts’ Top Healthcare Picks: Editas Medicine (EDIT), Viking Therapeutics (VKTX)

TIPRANKS
·
07 Mar

Viking Therapeutics: Promising Obesity Pipeline and Strategic Growth Catalysts Justify Buy Rating

TIPRANKS
·
06 Mar

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Insider Monkey
·
06 Mar

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

Zacks
·
05 Mar

Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire
·
05 Mar

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

Simply Wall St.
·
05 Mar

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
04 Mar

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Blockhead
·
03 Mar

ABBV Enters Obesity Bandwagon, Inks $2.2B Licensing Deal for Amylin Drug

Zacks
·
03 Mar

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
01 Mar

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
01 Mar

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Insider Monkey
·
27 Feb

Is Viking Therapeutics a Buy Right Now?

Motley Fool
·
26 Feb